500586-84-5

Upstream product

• 96-30-0 chloroacetylmethylamide 
• 824-79-3 sodium 4-methylbenzenesulfinate 

Downstream Products

• 952228-91-0 3-(2,2-dimethoxyethylidene)-1-methyl-5-(toluene-4-sulfonyl)piperidine-2,6-dione 
• 952228-92-1 3-(2,2-dimethoxyethyl)-1-methyl-5-(toluene-4-sulfonyl)piperidine-2,6-dione 
• 952228-93-2 6-(benzo[1,3]dioxol-5-yl)-5-(2,2-dimethoxyethyl)-1-methyl-3-(toluene-4-sulfonyl)-3,4-dihydro-1H-pyridin-2-one 
• 952228-94-3 1-methyl-8,9-(methylenedioxy)-3-(toluene-4-sulfonyl)-3,4-dihydro-1H-benzo[h]quinolin-2-one 
• 952228-95-4 1-methyl-8,9-(methylenedioxy)-3-(toluene-4-sulfonyl)-1H-benzo[h]quinolin-2-one 
• 864852-81-3 (4S)-isobutyl-(5S)-(2-methoxycarbonyl-1-methyl-5-oxo-4-(toluene-4-sulfonyl)-pyrrolidin-3-yl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

An efficient synthesis of N-alkyl-4-substituted 3H-pyridine-2,6-dione. Synthesis of isoguvacine and MDL-11,939

An efficient route towards the synthesis of N-alkyl-4-substituted 3H-pyridine-2,6-dione using various N-alkyl-α-sulfonylacetamides and two α,β-unsaturated esters as starting materials is described. Isoguvacine and MDL-11,939 with have potential biological activities were synthesized via this strategy.